These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34882269)

  • 1. Longitudinal evaluation of apparent diffusion coefficient values as a predictor of Prostate Cancer Research International Active Surveillance reclassification.
    Ota E; Mori N; Yamashita S; Mugikura S; Ito A; Takase K
    Abdom Radiol (NY); 2022 Feb; 47(2):814-826. PubMed ID: 34882269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of prostate cancer and stromal hyperplasia in the transition zone with histogram analysis of the apparent diffusion coefficient.
    Xiaohang L; Bingni Z; Liangping Z; Weijun P; Xiaoqun Y; Yong Z
    Acta Radiol; 2017 Dec; 58(12):1528-1534. PubMed ID: 28286980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of whole-lesion apparent diffusion coefficient analysis for predicting outcomes of prostate cancer patients on active surveillance.
    Tamada T; Dani H; Taneja SS; Rosenkrantz AB
    Abdom Radiol (NY); 2017 Sep; 42(9):2340-2345. PubMed ID: 28396920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor lesion diameter on diffusion weighted magnetic resonance imaging could help predict insignificant prostate cancer in patients eligible for active surveillance: preliminary analysis.
    Lee DH; Koo KC; Lee SH; Rha KH; Choi YD; Hong SJ; Chung BH
    J Urol; 2013 Oct; 190(4):1213-7. PubMed ID: 23727188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically insignificant prostate cancer suitable for active surveillance according to Prostate Cancer Research International: Active surveillance criteria: Utility of PI-RADS v2.
    Yim JH; Kim CK; Kim JH
    J Magn Reson Imaging; 2018 Apr; 47(4):1072-1079. PubMed ID: 28901655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance.
    Morgan VA; Riches SF; Thomas K; Vanas N; Parker C; Giles S; Desouza NM
    Br J Radiol; 2011 Jan; 84(997):31-7. PubMed ID: 21172965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance.
    Kim TH; Jeong JY; Lee SW; Kim CK; Park BK; Sung HH; Jeon HG; Jeong BC; Seo SI; Lee HM; Choi HY; Jeon SS
    Eur Radiol; 2015 Jun; 25(6):1786-92. PubMed ID: 25636416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Apparent Diffusion Coefficient as a Predictor of Grade Reclassification in Men on Active Surveillance for Prostate Cancer.
    Huang MM; Macura KJ; Landis P; Epstein JI; Gawande R; Carter HB; Mamawala M
    Urology; 2020 Apr; 138():84-90. PubMed ID: 31954166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Discussion of correlation between histogram analysis of quantitative diffusion weighted imaging and Gleason score of prostate cancer].
    Wen R; Zhao WL; Wei CG; Gu YF; Li MJ; Zhang YY; Shen JK
    Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(11):823-828. PubMed ID: 30893724
    [No Abstract]   [Full Text] [Related]  

  • 11. Serial changes in tumour measurements and apparent diffusion coefficients in prostate cancer patients on active surveillance with and without histopathological progression.
    Sushentsev N; Caglic I; Rundo L; Kozlov V; Sala E; Gnanapragasam VJ; Barrett T
    Br J Radiol; 2022 Mar; 95(1131):20210842. PubMed ID: 34538077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of PI-RADS 2, ADC histogram-derived parameters, and their combination for the diagnosis of peripheral zone prostate cancer.
    Lin WC; Westphalen AC; Silva GE; Chodraui Filho S; Reis RB; Muglia VF
    Abdom Radiol (NY); 2016 Nov; 41(11):2209-2217. PubMed ID: 27364781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stretched-exponential and mono-exponential diffusion-weighted imaging for assessing the aggressiveness of prostate cancer: A histogram analysis].
    Yu YN; Zhang SJ
    Zhonghua Nan Ke Xue; 2019 Dec; 25(12):1106-1112. PubMed ID: 32251563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring Tumor Volume in Patients With Prostate Cancer Undergoing Active Surveillance: Is MRI Apparent Diffusion Coefficient Indicative of Tumor Growth?
    Morgan VA; Parker C; MacDonald A; Thomas K; deSouza NM
    AJR Am J Roentgenol; 2017 Sep; 209(3):620-628. PubMed ID: 28609110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of breast masses as benign or malignant at 3.0T MRI with whole-lesion histogram analysis of the apparent diffusion coefficient.
    Suo S; Zhang K; Cao M; Suo X; Hua J; Geng X; Chen J; Zhuang Z; Ji X; Lu Q; Wang H; Xu J
    J Magn Reson Imaging; 2016 Apr; 43(4):894-902. PubMed ID: 26343918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histogram analysis from stretched exponential model on diffusion-weighted imaging: evaluation of clinically significant prostate cancer.
    Kim E; Kim CK; Kim HS; Jang DP; Kim IY; Hwang J
    Br J Radiol; 2020 Feb; 93(1106):20190757. PubMed ID: 31899654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate Cancer Diffusion-Weighted Magnetic Resonance Imaging: Does the Choice of Diffusion-Weighting Level Matter?
    Maier SE; Wallström J; Langkilde F; Johansson J; Kuczera S; Hugosson J; Hellström M
    J Magn Reson Imaging; 2022 Mar; 55(3):842-853. PubMed ID: 34535940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can whole-tumor apparent diffusion coefficient histogram analysis be helpful to evaluate breast phyllode tumor grades?
    Guo Y; Tang WJ; Kong QC; Liang YY; Han XR; Zheng BJ; Sun L; Wei XH; Jin Z; Liu CL
    Eur J Radiol; 2019 May; 114():25-31. PubMed ID: 31005172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.
    Choi MH; Oh SN; Rha SE; Choi JI; Lee SH; Jang HS; Kim JG; Grimm R; Son Y
    J Magn Reson Imaging; 2016 Jul; 44(1):212-20. PubMed ID: 26666560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Stratification of Prostate Cancer Using the Combination of Histogram Analysis of Apparent Diffusion Coefficient Across Tumor Diffusion Volume and Clinical Information: A Pilot Study.
    Zhang Z; Xu H; Xue Y; Li J; Ye Q
    J Magn Reson Imaging; 2019 Feb; 49(2):556-564. PubMed ID: 30173421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.